REGISTERED
on 16 Apr 2024
Last Applicant/ Owned by
City West Business Campus
Dublin
IE
24
Serial Number
97652310 filed on 28th Oct 2022
Registration Number
7361602 registered on 16th Apr 2024
Correspondent Address
Jeremy Blackowicz BAUSCH HEALTH COMPANIES
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
CABTREO
pharmaceutical preparations and substances for use in dermatological conditions and skin care disorders; pharmaceutical preparations and substances for the prevention and treatment of dermatological conditions and skin care disorders; pharmaceutical preparations and substances for dermatologic use, namely, topical preparations for the treatment of acne
Classification Information
Class [005]
Pharmaceutical Products
pharmaceutical preparations and substances for use in dermatological conditions and skin care disorders; pharmaceutical preparations and substances for the prevention and treatment of dermatological conditions and skin care disorders; pharmaceutical preparations and substances for dermatologic use, namely, topical preparations for the treatment of acne
First Use Date in General
22nd Jan 2024
First Use Date in Commerce
22nd Jan 2024
Mark Details
Serial Number
No 97652310
Mark Type
No Service/Collective Mark
Attorney Docket Number
No
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 30th May 2024 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| 16th Apr 2024 | REGISTERED-PRINCIPAL REGISTER |
| 16th Apr 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| 12th Mar 2024 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| 09th Mar 2024 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| 07th Mar 2024 | STATEMENT OF USE PROCESSING COMPLETE |
| 07th Mar 2024 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 15th Feb 2024 | TEAS STATEMENT OF USE RECEIVED |
| 15th Feb 2024 | USE AMENDMENT FILED |
| 14th Nov 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |